Transgenic targeting of a dominant negative corepressor to liver and analyses by cDNA microarray.
Feng
Xu
X
Molecular Regulation and Neuroendocrinology Section, Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Meltzer
Paul
P
Yen
Paul M
PM
D000818:Animals; D018076:DNA, Complementary; D018390:Gene Targeting / Q000379:methods*; D006801:Humans; D008099:Liver / Q000378:metabolism*; D051379:Mice; D008822:Mice, Transgenic; D009687:Nuclear Proteins / Q000235:genetics* / Q000502:physiology; D056971:Nuclear Receptor Co-Repressor 1; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D012097:Repressor Proteins / Q000235:genetics* / Q000502:physiology
D018076:DNA, Complementary; C539127:NCOR1 protein, human; C539128:Ncor1 protein, mouse; D009687:Nuclear Proteins; D056971:Nuclear Receptor Co-Repressor 1; D012097:Repressor Proteins